Merit Medical Systems Inc (MMSI) - Forward Price-to-Revenue Multiple

merit.com (MMSI) - corporate logo

Merit Medical Systems (MMSI) products for oncology and cardiology demonstrate steady long-term growth. The projected P/S dynamics confirm this trend, with the current level sitting around 1.90. Business stability is based on B2B supplies of disposable radiology instruments. The company's innovative sensors and catheters minimize surgical trauma, transforming engineering developments into effective life-saving methods.

MMSI merit.com: Forward Price-to-Revenue Multiple in the range 07/04/2022 - 11/13/2026

Merit Medical Corp - analytical breakdowns and key metrics (MMSI)

- market price and analyst price targets:
Price Chart Merit Medical|MMSI - Fair Value Consensus
- market capitalization indicators:
Market Valuation Merit Medical Systems|MMSI - Enterprise Value
- business book valuation details:
Net Assets per Single Share Merit Medical|MMSI - Company Net Assets|Market Capitalization to Book Value Ratio merit.com|MMSI - Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Merit Medical Systems|MMSI - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Merit Medical Systems|MMSI - Company Cumulative Indebtedness|Debt to Book Capitalization Ratio Merit Medical Systems|MMSI - Long-Term Debt Volume|Company Short-Term Debt Merit Medical|Quick Ratio merit.com
- business earnings and investment ratios data:
MMSI - Company Net Income|Expected Profit Merit Medical Systems|MMSI - Company Value to Net Income|Forward P/E Multiple Merit Medical Systems Inc|MMSI - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Merit Medical Systems|MMSI - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months Merit Medical|MMSI - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months merit.com|MMSI - Net earnings per share growth this year|Earnings growth forecast for next year Merit Medical Systems
- sales and revenue data:
MMSI - Company Total Revenue|Projected Sales Volume Merit Medical|MMSI - Market Cap to Revenue Ratio|Forward P/S Multiple Merit Medical Systems
General company analysis:MMSI (Merit Medical)
Original product of merit.com

The forward P/S reflects the market value of Merit Medical Systems (MMSI) relative to expected revenue, allowing investors to assess the extent of the premium or discount for future cash flows. Analyzing the forward P/S trend on the GURU.Markets platform reveals how strong patent protection and the deep integration of Merit Medical Systems (MMSI) devices into hospital practice ensure valuation stability even amidst fluctuations in consensus forecasts.

Analysis of competing companies

Price-to-Projected Revenue Ratio Intuitive ISRG|Forward Price to Sales DHR|BDX: Forward Price-to-Revenue Multiple|STE - Forward P/S Multiple|West Pharmaceutical Services (WST) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple baxter.com|MASI (Masimo) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Stevanato Group SpA STVN|Price-to-Projected Revenue Ratio Teleflex Inc (TFX)|Nobel Biocare - Market Cap to Projected Revenue|ICU Medical, Inc. - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio XRAY (dentsplysirona.com)|LMAT - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio AtriCure Inc ATRC|STAAR Surgical Corp (STAA) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Niagen|ZIMV (ZimVie Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio angiodynamics.com ANGO|Price-to-Projected Revenue Ratio Cerus (CERS)|TKNO (Alpha Teknova) - Forward Price to Sales|Forward P/S Multiple MGRM (Monogram Technologies Inc)|Market Cap to Expected Sales Ratio Sharps Technology Inc (STSS)|INFU: Forward Price-to-Revenue Multiple|utahmed.com - Price to Expected Revenue Ratio|KRMD (korumedical.com) - Forward Price-to-Revenue Multiple|Nyxoah SA - Forward Price to Sales|Price-to-Projected Revenue Ratio Microbot Medical Inc|Forward Price-to-Revenue Multiple Pro-Dex Inc. (PDEX)|Forward P/S Multiple ZTEK|ELUT - Market Cap to Future Revenue Ratio|Forward P/S Multiple MLSS (Milestone Scientific Inc.)|NXGL: Market Cap to Projected Revenue|Retractable Tech - Forward P/S Multiple|Market Cap to Expected Sales Ratio harvardbioscience.com HBIO|FEMY: Forward P/S Multiple|Forward Price-to-Revenue Multiple Meihua Medical Technologies Co., Ltd.|POAI (Predictive Oncology Inc) - Forward P/S Multiple|Forward P/S Multiple Callan JMB Corp|Price-to-Projected Revenue Ratio Atrion Corp (ATRI)|Price-to-Projected Revenue Ratio NURO (NeuroMetrix Corporation)